Amlobika HCT Tablet 5/40/12.5 Milligrams

Adult dose

This medication should be taken once daily, with or without food, along with water. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosage is as follows: - 5/20/12.5mg: Administered to patients whose blood pressure is not adequately controlled with Amlodipine/Olmesartan Medoxomil 5/20mg combination therapy. - 5/40/12.5mg: Administered to patients whose blood pressure is not adequately controlled with Amlodipine/Olmesartan Medoxomil 5/40mg.

Child dose

The safety and efficacy for pediatric patients under 18 years have not been established, so administration of this medication is not recommended.

This medication can cause severe harm to the fetus and newborn during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to this drug or its components, specific heart, kidney, or liver diseases, and pregnant or breastfeeding women should not take this medication. Patients with excessively low blood pressure, severe heart failure, or acute renal failure should not use this medication. For patients with low blood volume or low salt levels, hypotension may occur, so careful monitoring of the condition is necessary during administration. Patients with impaired kidney function, kidney transplant recipients, patients with renovascular hypertension, or those with liver dysfunction should exercise extra caution when using this medication. This medication lowers blood pressure, which may lead to dizziness or drowsiness, necessitating caution when driving or operating dangerous machinery. Some patients may experience increased sensitivity to sunlight, so sun exposure should be avoided, and if photosensitivity reactions occur, use should be discontinued. While taking this medication, regular blood tests should be conducted to monitor electrolyte levels and kidney function, particularly potassium levels. This medication may interact with other antihypertensive drugs, specific diuretics, lithium, and non-steroidal anti-inflammatory drugs (NSAIDs), so consultation with a physician is advised when used concurrently. Elderly individuals may be more sensitive to this medication, so starting at a lower dose and adjusting cautiously is recommended. In case of overdose, blood pressure may drop excessively, so healthcare personnel should be informed immediately for appropriate treatment. The safety and efficacy of this medication have not been established in children, so its use is not recommended.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mouth/eyes mucosa, difficulty breathing or shortness of breath, asthma attacks, cough with fever and respiratory distress, yellowing of skin or eyes (jaundice), extreme fatigue, sudden and very severe headache, thunderclap headache, seizure, confusion of consciousness, visual disturbances, paralysis, urination changes

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory tract infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly sealed container to protect it from air and moisture. It should also be kept away from extremely hot or cold places, ideally stored at room temperature between 1 degree and 30 degrees Celsius.

Appearance

Pale yellow, round, film-coated tablet

Package unit

28 tablets (14 tablets/PTP *2)